“Chimeric antigen receptor T-cell therapy for relapsed and refractory large B-cell lymphoma: A Canadian perspective”, Can Hematol Today, vol. 1, no. 2, pp. 26–33, Jul. 2022, doi: 10.58931/cht.2022.1214.